About Aspire Capital
Aspire Capital is a private equity firm founded in 2010. It is primarily based in Chicago, United States.
Overall Aspire Capital portfolio has seen 14 IPOs and 1 acquisition, namely Mereo BioPharma, Solid Biosciences and MediciNova. A lot of funds co-invest with Aspire Capital, with names like Suvretta Capital Management sharing a substantial percentage of its portfolio.
Aspire Capital has a team of 3 people, including 1 partner.
Key Metrics
Aspire Capital's Portfolio
They have invested in a total of 18 companies. Their most recent investment was in Satsuma Pharmaceuticals (Post IPO round) on Mar 01, 2021. Here is the most recent investment by Aspire Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Mar 01, 2021 | Post IPO | 3997 | ||
Dec 11, 2020 | Post IPO | 7914 | ||
Jul 22, 2020 | Post IPO | 7254 | - | |
Jul 01, 2020 | Post IPO | 8769 | - |
Here is the portfolio snapshot of Aspire Capital:
Investments by Year
The maximum number of investments were made in 2020
Team profile of Aspire Capital
Aspire Capital has a team of 3 members including 1 Partner and 2 Principals located in United States. Aspire Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Aspire Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | - | ||
Principal | Chicago | - | - | |
Principal | Chicago | - |
Co-investors of Aspire Capital
Over the past 16 years, 10 investors have co-invested in Aspire Capital's portfolio companies.
- Top Co-investors of Aspire Capital: 10 investors entered a company along with Aspire Capital. These include investors like Suvretta Capital Management (1 company).
Aspire Capital News
•
Ipass enters into a common stock purchase agreement with Aspire Capital Fund for up to $10 mlnReuters•Jul 25, 2024•iPass, Aspire Capital
•
Aspire Capital receives an offer to buy its share in the Egyptian Exchange, at a value of 89.9 million poundsAlalamelyoum•Feb 25, 2024•Aspire Capital
•
•
L’Attitude Ventures closes on $100M fund to back Latino founders of early-stage startupsTechCrunch+•Aug 03, 2022•L'ATTITUDE Ventures, Trujillo Group, Bank of America, RBC Royal Bank and 12 others
•
Athersys and Aspire Capital Fund Terminate RelationshipBusiness Wire•Jul 08, 2022•Aspire Capital, Athersys
•
Alternative investment platform Jiraaf bags $7.5 mn in Series A from Accel, othersBusiness Today•Jun 08, 2022•Jiraaf, Accel, Aspire Family Office, PharmEasy and 7 others
•
Satsuma Pharmaceuticals Announces $80 Million Private Placement FinancingGlobeNewswire•Mar 01, 2021•Satsuma Pharmaceuticals, Commodore Capital, New Enterprise Associates, RA Capital Management and 7 others
•
Aspire capital fund to purchase up to $20M of ordinary shares of VBL therapeuticsSeeking Alpha•Jan 15, 2021•Aspire Capital, VBL Therapeutics
•
Ocean Power Technologies Enters Into a New $12.5 Million Common Stock Purchase Agreement With Aspire Capital FundGlobeNewswire•Sep 18, 2020•Aspire Capital, Ocean Power Technologies
•
Intec Pharma Announces Pricing of $4.9 Million Registered Direct OfferingGlobeNewswire•Aug 07, 2020•IntecPharma, Aspire Capital
